Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

22 results about "Deinococcus" patented technology

Deinococcus (from the Greek: δεινός, deinos, "dreadful, strange" and κόκκος, kókkos, "granule") is one genus of three in the order Deinococcales of the bacterial phylum Deinococcus-Thermus highly resistant to environmental hazards. These bacteria have thick cell walls that give them Gram-positive stains, but they include a second membrane and so are closer in structure to Gram-negative bacteria. Deinococcus survive when their DNA is exposed to high doses of gamma and UV radiation. Whereas other bacteria change their structure in the presence of radiation, such as by forming endospores, Deinococcus tolerate it without changing their cellular form and do not retreat into a hardened structure. They are also characterized by the presence of the carotenoid pigment deinoxanthin that give them their pink color. They are usually isolated according to these two criteria.

Polypeptide and use thereof in cosmetics

PCT designated stageWO2025185662A1Cosmetic preparationsMake-upDeinococcusPharmaceutical drug
The present invention relates to multiple polypeptides with high safety, cell repair capacity, and anti-inflammatory, hydrating and moisturizing effects, and the use thereof in cosmetics, wherein the amino acid sequences of the polypeptides are as set forth in SEQ ID NO: 1-SEQ ID NO: 6. The present invention also relates to a polynucleotide encoding the polypeptides, wherein the sequence of the polynucleotide is as set forth in SEQ ID NO: 7-SEQ ID NO: 12, and the sequence of the polynucleotide can be used for the detection of Deinococcus weizhi. In addition, further provided is a topical drug or a cosmetic, which contains any one of the polypeptides or a combination thereof as an active ingredient.
Owner:HANGZHOU VICROBX BIOTECH CO LTD

Deinococcus weizhi and use thereof

The present invention provides a novel microbial strain resource, specifically relates to the identification of Deinococcus Weizhi as a new species, and provides specific Deinococcus weizhi VB142 and Deinococcus weizhie VB226. A fermentation broth, a fermentation product filtrate, a fermentation lysate, and extracts of the fermentation broth can be obtained by means of conventional fermentation, are applicable for the preparation of antioxidant products, and have wide application value and market prospects.
Owner:HANGZHOU VICROBX BIOTECH CO LTD

Deinococcus weizhi and use thereof

The present invention provides a novel microbial strain resource, specifically relates to the identification of Deinococcus Weizhi as a new species, and provides specific Deinococcus weizhi VB142 and Deinococcus weizhie VB226. A fermentation broth, a fermentation product filtrate, a fermentation lysate, and extracts of the fermentation broth can be obtained by means of conventional fermentation, are applicable for the preparation of antioxidant products, and have wide application value and market prospects.
Owner:HANGZHOU VICROBX BIOTECH CO LTD

Method for enhancing Escherichia coli electronic respiration transfer and energy transfer efficiency and improving L-threonine yield

PendingCN120591300ABacteriaTransferasesGenetic enhancementDeinococcus
The invention discloses a method for improving the yield of L-threonine by enhancing Escherichia coli electronic respiration transfer and energy transfer efficiency, and belongs to the technical field of genetic engineering. According to the invention, a cytochrome bo oxidase subunit CyoA mutant derived from escherichia coli, a cytochrome bo oxidase subunit CyoB mutant derived from pseudomonas aeruginosa, a cytochrome bd oxidase cydAB gene cluster derived from escherichia coli and a polyphosphate kinase PPK mutant derived from radiation-resistant coccus are introduced, amn genes are knocked out, and a cytochrome bo oxidase gene is obtained. The electron transfer efficiency in escherichia coli and the production efficiency of energy ATP (adenosine triphosphate) are enhanced, and the production efficiency of L-threonine and the carbon yield are further improved. Finally, the obtained engineering strain ECTHRS-5 is subjected to fed-batch fermentation in a 5L fermentation tank to accumulate 160.8 g / L of L-threonine, and the sugar-acid conversion rate is 0.62 g / g.
Owner:JIANGNAN UNIV

Application of a special bacterium in degrading malachite green wastewater

The application belongs to the field of microbial degradation of dyes, and relates to application of deinococcus in degradation of malachite green wastewater. The deinococcus is Deinococcus wulumuqiensis R12. When the initial concentration of malachite green MG is 200 mg / L, the cell concentration of R12 is 8.0 g / L, the reaction is carried out at 30 DEG C and pH 6.0 for 30 min, the degradation rate is 99.80%. When the initial concentration of MG is 1000 mg / L, the degradation rate can reach more than 95% after 1.5 h of reaction. Meanwhile, the R12 has wide adaptability to pH and temperature in degrading malachite green, and can efficiently degrade malachite green MG under the conditions of pH 5.0-10.0 and 10-45 DEG C.
Owner:YANGZHOU POLYTECHNIC INST

Polypeptide and application thereof in cosmetics

The invention relates to a plurality of polypeptides with high safety, cell repair capability, anti-inflammatory and moisturizing effects and application thereof in cosmetics, amino acid sequences of the polypeptides are shown as SEQ ID NO: 1-SEQ ID NO: 6, polynucleotides for encoding the polypeptides are also provided, the polynucleotide sequences are shown as SEQ ID NO: 7-SEQ ID NO: 12, and the polynucleotides are used for encoding the polypeptides. The polynucleotide sequence can be used for detecting deinococcus micrococci; the invention also provides an external medicine or a cosmetic, which comprises any one or a combination of the polypeptide as an active ingredient.
Owner:HANGZHOU VICROBX BIOTECH CO LTD

Microbial marker for schizophrenia with social anxiety disorder and application thereof

The invention provides a microbial marker for schizophrenia with social anxiety disorder and application of the microbial marker. The microbial marker is a deinococcus microorganism in saliva. The relevance between the content of the deinococcus microorganisms in saliva and social anxiety disorder is found for the first time. Moreover, by taking deinococcus microorganisms in saliva as potential microbial markers, objective biological indexes can be provided for early diagnosis and monitoring of the schizophrenia accompanied with social anxiety disorder, and errors of subjective evaluation are reduced; moreover, compared with the intestinal specific biomarker, the oral saliva sample has the obvious advantages of easiness in collection and the like for psychotic patients, and the working difficulty of medical personnel can be greatly reduced; besides, the specific microbial marker can be combined with a traditional psychological scale and other biomarkers to form a more comprehensive diagnosis mode, and revolutionary changes of prediction, diagnosis and treatment of schizophrenia with social anxiety disorder are expected to be brought.
Owner:FUJIAN PROVINCIAL HOSPITAL

Method for efficient traceless editing of myxobacteria genome and application

The invention discloses a method for efficient traceless editing of a myxobacteria genome and application. According to the invention, a TnpB cutting system ISDra2 of deinococcus radiodurans is combined with a homologous recombination system MxRedET of myxobacteria, so that a one-step traceless editing platform (MxDIRECT) is formed. The ISDra2 is responsible for accurately positioning and cutting target DNA, and the MxRedET immediately realizes efficient fragment integration or replacement at a cut, so that operations such as gene knockout, insertion and replacement are realized. According to the method, the editing efficiency of myxobacteria is improved to 100% from original 1%, the period is shortened to 5-7 days from 3-6 months, and one-step double-site traceless editing can be achieved through double-site design. The longest DNA of about 80 kb can be knocked out through a single incision, and the longest DNA can reach 200 kb through double incisions; and mononucleotide replacement can be carried out at any position, so that accurate base editing is realized. The technology provides an efficient and accurate tool for modifying functional genes and metabolic pathways of the myxobacteria chassis cells, and obviously promotes the research of synthetic biology.
Owner:SHANDONG UNIV

Dgfe2 gene for cultivating salt-tolerant microorganism

This invention discloses a Gobi abnormal coccus ( Deinococcus gobiensis Genes encoding ferritin in I-0 DgfE2 The nucleotide sequence of this gene is shown in SEQ ID NO. 1. The protein DgfE2 encoded by this gene has salt-tolerant function and can be used to cultivate salt-tolerant microorganisms, thus providing a reference for cultivating plants with salt-tolerant traits. The amino acid sequence of this protein is shown in SEQ ID NO. 2. After being subjected to 0.6 mol / L NaCl stress for 5 h, it contains... DgfE2 Salt-tolerant recombinant strain pET28a- DgfE2 The growth of the / BL21 strain was better than that of the control pET28a / BL21 strain containing only an empty plasmid, indicating that this recombinant strain has the ability to tolerate salt stress. DgfE2 DgfE2 The gene has the function of improving the salt tolerance of E. coli.
Owner:SOUTHWEAT UNIV OF SCI & TECH

Polypeptide and use thereof in cosmetics

PCT designated stageWO2025185662A8Cosmetic preparationsMake-upDeinococcusPharmaceutical drug
The present invention relates to multiple polypeptides with high safety, cell repair capacity, and anti-inflammatory, hydrating and moisturizing effects, and the use thereof in cosmetics, wherein the amino acid sequences of the polypeptides are as set forth in SEQ ID NO: 1-SEQ ID NO: 6. The present invention also relates to a polynucleotide encoding the polypeptides, wherein the sequence of the polynucleotide is as set forth in SEQ ID NO: 7-SEQ ID NO: 12, and the sequence of the polynucleotide can be used for the detection of Deinococcus weizhi. In addition, further provided is a topical drug or a cosmetic, which contains any one of the polypeptides or a combination thereof as an active ingredient.
Owner:HANGZHOU VICROBX BIOTECH CO LTD

Enhanced tnpb polypeptide and use in genomic editing

In one aspect, the invention relates to a TnpB variant polypeptide comprising a Deinococcus radiodurans (ISDra2) TnpB polypeptide sequence and, separated by a peptide linker, a nuclear localization module comprising at least two nuclear localization sequences (NLS) separated by a first peptide linker. A second aspect of the invention relates to a DNA editing polypeptide comprising the TnpB variant polypeptide according to the invention, wherein the TnpB variant polypeptide comprises a nuclease deactivating mutation, and a nucleoside deaminase. The invention further relates to a nucleic acid sequence encoding a polypeptide according to the invention, and to a virus comprising the nucleic sequence.
Owner:UNIVERSITY OF ZURICH

A fermentation process for the simultaneous production of superoxide dismutase and silver nanoparticles and product composition

ActiveCN120230726BCosmetic preparationsBacteriaDismutaseDeinococcus
The present application belongs to the field of microbial fermentation and its metabolites, and particularly relates to a fermentation method and product composition for simultaneously producing superoxide dismutase and nano silver particles. The present application utilizes the stress tolerance characteristics of Deinococcus radiodurans, controls the concentration of Ag+, improves the enzyme activity of the oxidoreductase of Deinococcus radiodurans including SOD, and at the same time, Ag+ is reduced into nano silver particles (DR-Ag NPs). After the stress of Ag+ on Deinococcus radiodurans, the product is rich in oxidoreductase including SOD and nano silver particles (DR-Ag NPs), and after compounding with hyaluronic acid and the like, a functional cosmetic product can be prepared, which has super strong anti-aging, anti-wrinkle, whitening, antibacterial and anti-inflammatory effects, and at the same time, the use of preservatives is avoided.
Owner:GUANGDONG DUANMU BIOMEDICAL TECHNOLOGY CO LTD

Preparation method of laccase-like SiO2-CeO2 composite nanomaterial

The invention provides a preparation method of a laccase-like SiO2 / CeO2 composite nanomaterial, which adopts a biosynthesis method and comprises the following steps: S1, synthesis of a precursor SiO2: uniformly mixing hexadecyl trimethyl ammonium bromide, a sodium hydroxide aqueous solution and ethanol in deionized water, dropwise adding tetraethyl orthosilicate, and centrifuging, washing and calcining after the reaction is finished to obtain SiO2; s2, synthesis of the SiO2 (at) CeO2 composite nanomaterial: mixing the SiO2 aqueous solution prepared in the step S1 and the (CH3CO2) 3Ce aqueous solution, adding a deinococcus radiodurans R12 cell-free supernatant in a stable phase for incubation, centrifuging, washing, collecting precipitate after incubation is finished, freeze-drying overnight, and calcining to obtain the SiO2 (at) CeO2 composite nanomaterial. The laccase-like SiO2 / CeO2 composite nano material is successfully synthesized by using a sterile supernate system in a growth stable period of deinococcus radiodurans, and the laccase-like blank of a non-copper-based nano material is filled. And the preparation method is simple, low in cost and easy to implement, and lays a solid foundation for industrial production of the laccase-like enzyme.
Owner:NANJING TECH UNIV

Bacillus orientalis and application thereof

The invention discloses bacillus toonensis, which is preserved in the China General Microbiological Culture Collection Center (CGMCC), the preservation date is February 2, 2024, and the preservation number is CGMCC No.29852. The bacillus toonensis belongs to the eubacterium field, the posterior mycophylum, the bacilli, the bacillus family and the bacillus genus. The bacterial suspension of the bacillus orientalis can be used for degrading cellulose, starch and straw.
Owner:ZUNYI CITY BRANCH OF GUIZHOU TOBACCO COMPANY +2

Complex microbial inoculant for repairing saline-alkali soil and application of complex microbial inoculant

PendingCN120924435AAgriculture tools and machinesBacteriaSphingobium chlorophenolicumDeinococcus
The invention discloses a complex microbial inoculant for repairing saline-alkali soil and application of the complex microbial inoculant, and belongs to the technical field of microorganisms. The preparation method comprises the following steps: respectively carrying out fermentation culture on sphingobacterium bambusae and deinococcus cellulosilyticus, carrying out centrifugal resuspension, and mixing the obtained bacterial solutions, so as to prepare the composite bacterial agent for repairing the soil of the saline-alkali land. The preparation method comprises the following steps: carrying out fermentation culture on the sphingobacterium bambusae and the deinococcus cellulosilyticus respectively, and carrying out centrifugal resuspension on the obtained bacterial solutions, so as to obtain the composite bacterial agent for repairing the soil of the saline-alkali land. According to the invention, the complex microbial inoculant is applied to saline-alkali soil by using crushed corn straw as a carrier; experimental results show that the complex microbial inoculant can efficiently reduce the pH value and salt content of the saline-alkali soil and improve the organic matter content of the saline-alkali soil. A novel microbial material and an efficient remediation method are provided for improvement and remediation of the saline-alkali soil, the steps are simple, the effect is lasting and stable, and the method has prominent practical application value and wide application prospects.
Owner:JINZHONG UNIV

Microbial marker, diagnosis model and kit for early diagnosis of sensorineural deafness and application

The invention discloses a microbial marker, a diagnostic model and a kit for early diagnosis of sensorineural deafness and application. The microbial marker comprises at least one of abnormal coccus, cilia, Ackermann muciniphile and actinomycetes. Experiments find that compared with healthy control, the relative abundance of abnormal coccus, cilia, Ackerman muciniphile and actinomycetes on the skin surface of the external auditory canal of a patient suffering from SSHL (sensorineural deafness) is obviously increased, and by detecting the relative abundance of the microbial marker, high-accuracy early diagnosis and evaluation of SSHL are achieved, so that the SSHL can be used for early diagnosis and evaluation of the external auditory canal of the patient suffering from the sensorineural deafness. Therefore, early intervention and treatment of diseases are facilitated. Besides, the method is simple and convenient in sampling and simple in operation method, is widely applicable to people with poor cognition and compatibility, realizes noninvasive and age-limit-free SSHL early screening, and has wide market application prospects and social benefits.
Owner:LIANYUNGANG SECOND PEOPLES HOSPITAL (LIANYUNGANG CLINICAL TUMOR RES INST)

Deinococcus micrococci and application thereof

The invention provides a new microbial strain resource, particularly relates to identification of Deinococcus weishi as a new strain, and provides specific Deinococcus weishi VB142 and Deinococcus weishi VB226 which are subjected to conventional fermentation to obtain fermentation liquor, fermentation product filtrate, fermentation lysate and extract of the fermentation liquor, and the fermentation liquor, the fermentation product filtrate, the fermentation lysate and the extract of the fermentation liquor can be used for preparing antioxidant products. Wide application values and market prospects are realized.
Owner:HANGZHOU VICROBX BIOTECH CO LTD

Thioredoxin DrTrx2 from deinococcus radiodurans and application thereof

PendingCN120695166APeptide/protein ingredientsDisease diagnosisDeinococcusHeavy ion radiation
The invention relates to application of thioredoxin DrTrx2 coming from deinococcus radiodurans and having an anti-radiation function in preparation of drugs, the drugs are used for improving the anti-radiation capacity of organisms, and the amino acid sequence of the thioredoxin DrTrx2 is shown as SEQ ID NO.3. The thioredoxin DrTrx2 has the anti-radiation function, is most sensitive when responding to heavy ion radiation, and has the anti-radiation function. And the single protein has an anti-radiation function and can be used as a radiation-resistant functional component.
Owner:ACADEMY OF MILITARY MEDICAL SCIENCES

Method for preparing targeted nuclear drug by reducing nuclide lutetium 177 through biological agent

The invention belongs to the technical field of radioactive nuclear drugs, and particularly relates to a method for preparing a targeted nuclear drug by reducing nuclide lutetium-177 through a biological preparation, and the method comprises the following steps: step 1, activating and culturing a deinococcus radiodurans strain to obtain a deinococcus radiodurans thallus; and 2, adding the deinococcus radiodurans thalli into a nuclide lutetium chloride 177 LuCl3 solution, and incubating, so as to obtain the deinococcus radiodurans targeted nuclear drug loaded with lutetium 177. The deinococcus radiodurans obtained by the method provided by the invention has strong adsorption effect and binding capacity on lutetium-177, and can effectively reduce the preparation cost of the targeted nuclear drug; the prepared targeting nuclear drug is high in biological safety and enhanced in targeting property.
Owner:ZHEJIANG QINSHAN TECHNOLOGY CO LTD +1

Photoacoustic contrast agent based on reversible optical switch fusion protein, preparation method therefor, and use thereof

A photoacoustic contrast agent based on a reversible optical switch fusion protein, a preparation method therefor, and use thereof. The photoacoustic contrast agent comprises a phytochrome protein and a collagen-binding domain fused to the C-terminus of the phytochrome protein. The phytochrome protein is derived from Deinococcus radiodurans. The photoacoustic contrast agent combines the phytochrome protein derived from Deinococcus radiodurans and the collagen-binding domain, ingeniously integrating the optical switch function of DrBphP and the high affinity of the CBD for collagen. The DrBphP-CBD fusion protein retains the high affinity for type I collagen and type III collagen and its optical switch property. The photoacoustic contrast agent can be specifically attached to exposed collagen by utilizing the non-typical vascular structure of tumors and the excessive deposition of collagen in fibrotic diseases, thereby facilitating continuous delivery and retention in the affected tissue microenvironment and providing enhanced optical switch photoacoustic differential imaging for pathological section staining and in vivo imaging detection of diseases.
Owner:SHENZHEN UNIV

Preparation method and application of deinococcus radiodurans metagen

PendingCN121753880ABacteriaFood processingBiotechnologyDeinococcus
The invention discloses a preparation method and application of a deinococcus radiodurans metagen. The preparation method comprises the following steps: (1) preparing liquid seeds; (2) solid state fermentation: 5-8% (v / w) of the liquid seed liquid obtained in the step (1) is inoculated to a solid fermentation culture medium, the solid fermentation culture medium is prepared from, by mass, 50-60% of soybean meal, 30-40% of sunflower seeds, 4-12% of flaxseed meal and 2-8% of palm pomace, and constant-temperature fermentation is performed at 28-32 DEG C for 48-60 h; and (3) post-treatment: after the fermentation is finished, drying the fermented material at a low temperature of 55-65 DEG C until the moisture is less than or equal to 5% to obtain the deinococcus radiodurans metagen powder. The microencapsulation embedding method comprises the following steps: (1) preparing a wall material solution, (2) dispersing a core material, (3) forming microcapsules, and (4) carrying out post-treatment.The technical problems that active substances in deinococcus radiodurans metabiotics are easy to degrade and low in bioavailability in the pet food processing and digestion process and cannot stably exert the functions of oxidation resistance and flora regulation are solved.
Owner:YUANYI (HANGZHOU) TECH CO LTD